Chrome Extension
WeChat Mini Program
Use on ChatGLM

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women with Recurrent Platinum-Resistant/refractory Epithelial Ovarian Cancer.

Journal of Clinical Oncology(2013)

Cited 48|Views24
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined